Delivery Order SPE2DB24D2205-SPE2DB24FEAHA

Award Date 9/23/24
Potential Completion Date 9/24/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.5 mL VISCOAT syringes. The $5,065.40 firm-fixed-price contract has a completion date of May 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,349.54 fixed-price delivery order is for the supply of 0.5 mL VISCOAT syringes, with a completion date of February 26, 2025. This contract award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of 0.5 mL VISCOAT syringes to the U.S. Defense Logistics Agency (DLA). The firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $2,022.30. The contract has an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly...
This $21,290.28 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5 mL VISCOAT syringes. The order has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities supporting...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,068.05 firm fixed-price delivery order is for the supply of 0.5 mL VISCOAT syringes, with a performance period extending through May 7, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical sourcing and distribution services company. The $4,841.35 contract is for the delivery of 0.5 mL VISCOAT syringes. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 0.5 mL VISCOAT syringes to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,895.28 and a completion date of April 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,131.62 firm fixed price contract is for the delivery of VISCOAT SYRINGE 0.5ML medical supplies, with a completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order with a firm fixed price of $11,523.46 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.75 mL VISCOAT syringes, with a period of performance through January 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $7,339.02 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.5 mL VISCOAT Syringes. This award was not subject to any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on a DLA-awarded indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FEAHA
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5 mL VISCOAT syringes. The contract, valued at $4,666.80, has a completion date of September 24, 2024. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' hospitals, and other government healthcare programs. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice, valued at up to $999,999,999 and $750,000 respectively, for delivering a comprehensive range of essential medical commodities to federal beneficiaries. This contract award is not designated as a set-aside.

Generated 12/23/24, 2:46 PM